Related NCI Initiatives

Innovative Molecular Analysis Technologies

The NCI's Innovative Molecular Analysis Technologies (IMAT) Program supports research projects to develop and carry out pilot applications of novel technologies that will enable the molecular analysis of cancers and their host environment in support of basic, clinical, and epidemiological research.

Technologies supported through the IMAT program include those that:

• Detect alterations and instabilities of genomic DNA
• Measure the expression of genes and gene products
• Analyze and detect gene and/or cellular products including post-translational modification and function of proteins
• Identify and characterize exogenous infectious agents in cancer
• Assay the function of major signal transduction networks involved in cancer
• Apply novel methods of biomolecule sample preparation

For more information about IMAT, visit http://imat.cancer.gov.